Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim van Os

Showing results (51-60 of 767) with videos related to

Pageof 77
Sort By:
Therapeutic Advances in Psychopharmacology|September 2, 2021
Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort studyPeter C Groot, Jim van Os
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 27, 2023
Managing withdrawal symptoms using tapering stripsPeter C Groot, Jim van Os
Therapeutic Advances in Psychopharmacology|September 21, 2020
Outcome of antidepressant drug discontinuation with taperingstrips after 1-5 yearsPeter C Groot, Jim van Os
The American Journal of Psychiatry|February 3, 2015
Maternal C-reactive protein and schizophreniaJean-Paul Selten, Jim van Os
Annual Review of Clinical Psychology|March 3, 2010
Systematic reviews of categorical versus continuum models in psychosis: evidence for discontinuous subpopulations underlying a psychometric continuum. Implications for DSM-V, DSM-VI, and DSM-VIIRichard J Linscott, Jim van Os
Therapeutic Advances in Psychopharmacology|July 24, 2020
How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medicationPeter C Groot, Jim van Os
BMJ (Clinical Research Ed.)|January 22, 2013
Can we identify and treat "schizophrenia light" to prevent true psychotic illness?Jim van Os, Robin M Murray
Lancet (London, England)|May 8, 2012
Antipsychotic drugs for prevention of relapseJim van Os, Oliver D Howes
Therapeutic Advances in Psychopharmacology|May 18, 2023
Outcomes of hyperbolic tapering of antidepressantsJim van Os, Peter C Groot
The Lancet. Public Health|January 9, 2020
Tackling rising numbers of opioid prescriptions usersPeter C Groot, Jim van Os
Pageof 77

Showing results (51-60 of 767) with videos related to

Sort By:
Pageof 77
Therapeutic Advances in Psychopharmacology|September 2, 2021
Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort studyPeter C Groot, Jim van Os
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 27, 2023
Managing withdrawal symptoms using tapering stripsPeter C Groot, Jim van Os
Therapeutic Advances in Psychopharmacology|September 21, 2020
Outcome of antidepressant drug discontinuation with taperingstrips after 1-5 yearsPeter C Groot, Jim van Os
The American Journal of Psychiatry|February 3, 2015
Maternal C-reactive protein and schizophreniaJean-Paul Selten, Jim van Os
Annual Review of Clinical Psychology|March 3, 2010
Systematic reviews of categorical versus continuum models in psychosis: evidence for discontinuous subpopulations underlying a psychometric continuum. Implications for DSM-V, DSM-VI, and DSM-VIIRichard J Linscott, Jim van Os
Therapeutic Advances in Psychopharmacology|July 24, 2020
How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medicationPeter C Groot, Jim van Os
BMJ (Clinical Research Ed.)|January 22, 2013
Can we identify and treat "schizophrenia light" to prevent true psychotic illness?Jim van Os, Robin M Murray
Lancet (London, England)|May 8, 2012
Antipsychotic drugs for prevention of relapseJim van Os, Oliver D Howes
Therapeutic Advances in Psychopharmacology|May 18, 2023
Outcomes of hyperbolic tapering of antidepressantsJim van Os, Peter C Groot
The Lancet. Public Health|January 9, 2020
Tackling rising numbers of opioid prescriptions usersPeter C Groot, Jim van Os
Pageof 77